Prothena | Activos Circulantes



Current Assets Cambio Fecha
Acadia Pharmaceuticals USD 938.32M 150.03M 2024-12
Agios Pharmaceuticals USD 965.6M 108.59M 2024-12
ALKERMES USD 1.42B 167.74M 2024-12
Alnylam Pharmaceuticals USD 3.3B 60.14M 2024-12
Amgen USD 29.03B 2.26B 2024-12
Biogen USD 7.46B 626.3M 2024-12
BioMarin Pharmaceutical USD 3.23B 175.84M 2024-12
Exelixis USD 1.47B 82.14M 2025-01
Incyte USD 3.24B 430.32M 2024-12
Ionis Pharmaceuticals USD 2.62B 93.56M 2024-12
MacroGenics USD 217.49M 4.71M 2024-12
Neurocrine Biosciences USD 1.72B 151.9M 2024-12
Prothena USD 485.41M 49.57M 2024-12
Regeneron Pharmaceuticals USD 27.21B 7.88B 2024-12
Ultragenyx Pharmaceutical USD 817.12M 17.52M 2024-12
Vertex Pharmaceuticals USD 9.6B 207.7M 2024-12



Prothena Activos Circulantes - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2025.